EUVIMEDEUVIMED entdecken
Crossref

Subareolar sclerosing ductal hyperplasia shows PI3K pathway alterations

Baris Boyraz iD, Brian Robinson, Neal Lindeman iD, Syed A Hoda, James P Solomon iD

Histopathology · 2025

DOI: 10.1111/his.15416 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Histopathology, 2025. Verfasst von Baris Boyraz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY, USA. Hauptthemen laut MEDLINE: Phosphatidylinositol 3-Kinases, Breast Neoplasms. Die Arbeit nennt 17 Literaturangaben. Gefördert von: Weill Cornell Medicine/New York-Presbyterian Hospital Translational Research Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Subareolar sclerosing ductal hyperplasia (SSDH) is a distinct type of complex sclerosing hyperplastic lesion first described by Rosen in 1987. There have been rare studies investigating SSDH; however, no genetic study has been performed to date. Methods and results Seven SSDH cases, diagnosed between 2013 and 2024, were identified. All were subjected to next‐generation sequencing (523 genes). Patient ages ranged from 40 to 74 years (median = 46). All lesions were located in the subareolar region. Each showed the characteristic appearance of the lesion, as described in the seminal study, with usual ductal hyperplasia in a densely sclerotic background imparting an ‘infiltrative’ appearance. None of the cases showed atypical hyperplasia or carcinoma. DNA sequencing identified PI3K pathway alterations in all seven cases: PIK3CA ( n = three, one with two alterations), PIK3R1 ( n = three) and PIK3C3 ( n = one, with concurrent FAT1 mutation).

Conclusion

SSDH shows PI3K pathway alterations similar to those seen in other non‐atypical and atypical proliferative lesions as well as benign and malignant neoplasms of the breast. This finding may explain the rare association of SSDH with atypical hyperplasia, in‐situ and invasive carcinoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Phosphatidylinositol 3-KinasesBreast NeoplasmsHumansFemaleHyperplasiaAgedMiddle AgedAdultClass I Phosphatidylinositol 3-KinasesSignal TransductionBreastMutationHigh-Throughput Nucleotide SequencingSclerosis

Stichwörter der Autor:innen

PI3Kbreastsubareolar sclerosing duct hyperplasia

Substanzen

Class I Phosphatidylinositol 3-KinasesPhosphatidylinositol 3-KinasesPIK3CA protein, human

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY, USA.

ORCID-Profile: Baris Boyraz, Neal Lindeman, James P Solomon

Förderung

  • Weill Cornell Medicine/New York-Presbyterian Hospital Translational Research Program

Zitieren

APA

Boyraz, B., Robinson, B., Lindeman, N., Hoda, S. A., & Solomon, J. P. (2025). Subareolar sclerosing ductal hyperplasia shows PI3K pathway alterations. Histopathology. https://doi.org/10.1111/his.15416

Vancouver

Boyraz B, Robinson B, Lindeman N, Hoda SA, Solomon JP. Subareolar sclerosing ductal hyperplasia shows PI3K pathway alterations. Histopathology. 2025. doi:10.1111/his.15416

BibTeX
@article{Boyraz2025,
  author = {Boyraz, Baris and Robinson, Brian and Lindeman, Neal and Hoda, Syed A and Solomon, James P},
  title = {Subareolar sclerosing ductal hyperplasia shows PI3K pathway alterations},
  journal = {Histopathology},
  year = {2025},
  doi = {10.1111/his.15416}
}
Kostenlos starten →